Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial: 达格列净治疗接受二甲双胍治疗失败的 …
W Yang, P Han, KW Min, B Wang… - Journal of …, 2016 - Wiley Online Library
… Given that modest weight loss contributes … weight gain,8 the weight-lowering effects of
dapagliflozin represent an added clinical benefit for many patients. Weight loss with dapagliflozin …
dapagliflozin represent an added clinical benefit for many patients. Weight loss with dapagliflozin …
Efficacy and safety of dapagliflozin in Asian patients: A pooled analysis: 达格列净在亚洲2 型糖尿病患者中的有效性与安全性: 一项汇总分析
W Yang, L Ji, Z Zhou, VA Cain, KM Johnsson… - Journal of …, 2017 - Wiley Online Library
… In addition, drug-induced glucosuria has been associated with caloric elimination leading
to weight loss, as well as with osmotic diuresis leading to reductions in blood pressure.20, 21 …
to weight loss, as well as with osmotic diuresis leading to reductions in blood pressure.20, 21 …
Dapagliflozin as add‐on therapy in Asian patients with type 2 diabetes inadequately controlled on insulin with or without oral antihyperglycemic drugs: A randomized …
W Yang, J Ma, Y Li, Y Li, Z Zhou, JH Kim… - Journal of …, 2018 - Wiley Online Library
… This weight loss results from urinary loss of calories via glucosuria, which causes a negative
net energy balance, and both reduced subcutaneous and visceral adipose tissue have …
net energy balance, and both reduced subcutaneous and visceral adipose tissue have …
Sodium glucose transporter 2 inhibition: A new approach to diabetes treatment (抑制钠葡萄糖转运体2: 一种新的糖尿病治疗方法).
Z Bloomgarden - Journal of Diabetes, 2013 - search.ebscohost.com
… ,8 with a study of dapagliflozin added to metformin showing a … , dapagliflozin was associated
with significant weight loss … Dapagliflozin is approved for the treatment of type 2 diabetes …
with significant weight loss … Dapagliflozin is approved for the treatment of type 2 diabetes …
达格列净对超重或肥胖T2DM 患者血管内皮功能和动脉硬化影响的研究
李倩 - 2021 - ir.lzu.edu.cn
… After 6 months, weight, BMI, hsCRP, SBP and TDD in the dapagliflozin group were lower
than the control group, and the differences were statistically significant(p<0.05);FBG, 2hPG, …
than the control group, and the differences were statistically significant(p<0.05);FBG, 2hPG, …
达格列净改善超重及肥胖2 型糖尿病患者脂代谢及内脏脂肪含量
姜立娟, 刘福强, 蒋子允, 李文娟, 林鹏… - 山东大学学报 …, 2022 - yxbwk.njournal.sdu.edu.cn
… group(n=30)and dapagliflozin(Adatang)treatment group(n=30). … In the dapagliflozin treatment
group, 10 mg/d dapagliflozin was … of antidiabetic drugs with weight loss effect: an evidence …
group, 10 mg/d dapagliflozin was … of antidiabetic drugs with weight loss effect: an evidence …
Beneficial effects of sodium–glucose cotransporter 2 inhibitors for preservation of pancreatic β‐cell function and reduction of insulin resistance: 钠‐葡萄糖共转运体2 …
H Kaneto, A Obata, T Kimura, M Shimoda… - Journal of …, 2017 - Wiley Online Library
… that treatment with the SGLT2 inhibitor dapagliflozin facilitated … , patients treated with
dapagliflozin had lower blood glucose … Finally, dapagliflozin treatment was found to further …
dapagliflozin had lower blood glucose … Finally, dapagliflozin treatment was found to further …
SGLT2 抑制剂对糖尿病肾病患者的影响: 基于尿足细胞的初步研究
… mass index level and weight loss were significant for the … Dapagliflozin treatment in patients
with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight…
with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight…
[引用][C] Increased grip strength with sodium–glucose cotransporter 2: 握力增加与钠‐葡萄糖共转运体‐2
M Sano, S Meguro, T Kawai, Y Suzuki - Journal of Diabetes, 2016 - Wiley Online Library
… fat reduction, weight loss, and volume reduction due to a mild diuretic effect. Sarcopenia is
a … Subjects were treated with ipragliflozin 50 mg, luseogliflozin 2.5mg, or dapagliflozin 5 or …
a … Subjects were treated with ipragliflozin 50 mg, luseogliflozin 2.5mg, or dapagliflozin 5 or …
[HTML][HTML] 达格列净对新诊断超重及肥胖2 型糖尿病患者糖脂代谢及尿微量白蛋白的影响
王亚迪, 申黎艳, 李阳, 李鹏, 孟冬梅 - Advances in Clinical Medicine, 2022 - hanspub.org
… The observation group was treated with dapagliflozin combined with metformin on the …
treatment (t = 6.022, P < 0.001), and there was a statistically significant difference in weight loss …
treatment (t = 6.022, P < 0.001), and there was a statistically significant difference in weight loss …